ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CARA Cara Therapeutics Inc

0.6843
-0.0157 (-2.24%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Cara Therapeutics Inc CARA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.0157 -2.24% 0.6843 07:11:01
始値 安値 高値 終値 前日終値
0.69 0.68 0.7264 0.6843 0.70
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0220:00GLOBECara Therapeutics to Present at the 23rd Annual Needham..
2024/3/0721:00GLOBECara Therapeutics to Host Notalgia Paresthetica (NP) Virtual..
2024/3/0706:45EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0506:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:10EDGAR2Form 8-K - Current report
2024/3/0506:01GLOBECara Therapeutics Announces Fourth Quarter and Full Year..
2024/2/1408:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1307:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1307:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1307:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1306:01GLOBECara Therapeutics to Announce Fourth Quarter and Full Year..
2024/2/0606:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0606:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0306:59EDGAR2Form 8-K - Current report
2024/1/3005:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2306:19EDGAR2Form 8-K - Current report
2024/1/2221:00GLOBECara Therapeutics Prioritizes Late-Stage Notalgia..
2023/12/1821:10EDGAR2Form 8-K - Current report
2023/12/1821:00GLOBECara Therapeutics Announces Outcome from Dose-Finding Part A..
2023/11/1406:28EDGAR2Form 8-K - Current report
2023/11/1406:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1406:11EDGAR2Form 8-K - Current report
2023/11/1406:01GLOBECara Therapeutics Reports Third Quarter 2023 Financial..
2023/11/0405:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0220:10EDGAR2Form 8-K - Current report
2023/11/0220:00GLOBECara Therapeutics Announces up to $40.0 Million Non-Dilutive..
2023/10/2320:00GLOBECara Therapeutics to Announce Third Quarter 2023 Financial..
2023/9/2520:00GLOBECara Therapeutics Announces Approval of KORSUVA® IV..
2023/9/0520:00GLOBECara Therapeutics to Present at the H.C. Wainwright 25th..
2023/8/0805:24EDGAR2Form 8-K - Current report
2023/8/0805:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0805:10EDGAR2Form 8-K - Current report
2023/8/0805:01GLOBECara Therapeutics Reports Second Quarter 2023 Financial..
2023/8/0506:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0506:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0320:06EDGAR2Form 8-K - Current report
2023/8/0320:00GLOBECara Therapeutics Appoints Helen M. Boudreau to Board of..
2023/8/0220:00GLOBECara Therapeutics to Present at the Canaccord Genuity 43rd..
2023/7/2605:40EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/7/2420:00GLOBECara Therapeutics to Announce Second Quarter 2023 Financial..
2023/6/0307:46PRNUSPalo Alto Networks Set to S&P 500; Others to Join S&P MidCap..
2023/6/0120:00GLOBECara Therapeutics to Present at the Jefferies Healthcare..
2023/5/1815:00GLOBEKapruvia® (difelikefalin) recommended by England’s NICE for..
2023/5/1605:01GLOBECara Therapeutics Reports First Quarter 2023 Financial..

最近閲覧した銘柄

Delayed Upgrade Clock